Search Results - "Diaz Galvez, Francisco Javier"
-
1
S100 expression by atypical megakaryocytes: a previously unreported potential pitfall in dermatopathology
Published in Journal of cutaneous pathology (01-12-2014)“…Several types of large atypical epithelioid cells can mimic tumoral melanocytes and can therefore be a source of misdiagnosis of melanoma. Megakaryocytes are…”
Get full text
Journal Article -
2
Liquid biopsy: a non‐invasive approach for Hodgkin lymphoma genotyping
Published in British journal of haematology (01-11-2021)“…Summary The Hodgkin lymphoma (HL) genomic landscape is hardly known due to the scarcity of tumour cells in the tissue. Liquid biopsy employing circulating…”
Get full text
Journal Article -
3
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice
Published in Blood (08-08-2024)“…•Similar to clinical trial results, fostamatinib has demonstrated a high efficacy rate for ITP in daily clinical practice conditions.•Fostamatinib is a…”
Get full text
Journal Article -
4
Cutaneous findings in a case of Mediterranean spotless fever due to Rickettsia conorii, with gangrene of multiple toes
Published in The American journal of dermatopathology (01-02-2014)“…Mediterranean spotted fever (MSF) is a tick-borne disease caused by Rickettsia conorii conorii. Some rare cases present without a rash, and they are known as…”
Get full text
Journal Article -
5
Use of eltrombopag after romiplostim in primary immune thrombocytopenia
Published in British journal of haematology (01-04-2015)“…Summary The thrombopoietin receptor agonists (THPO‐RAs), romiplostim and eltrombopag, are effective and safe in immune thrombocytopenia (ITP). However, the…”
Get full text
Journal Article -
6
Pharmacogenetic Study of Ibrutinib Toxicity in Chronic Lymphocytic Leukemia Patients
Published in Blood (15-11-2022)Get full text
Journal Article -
7
Early Identification of Very High Risk Patients with Diffuse Large B Cell Lymphoma (DLBCL) By PET-CT
Published in Blood (02-11-2023)“…TITLE Early identification of very high risk patients with Diffuse Large B Cell Lymphoma (DLBCL) by PET-CT. INTRODUCTION Early identification of high risk…”
Get full text
Journal Article -
8
Efficacy and Safety of Fostamatinib for Immune Thrombocytopenia in Clinical Practice in Spain: Interim Results of Fostames, Our National Fostamatinib Registry
Published in Blood (02-11-2023)“…Background: Fostamatinib is a splenic tyrosine kinase (SYK) inhibitor that prevents antibody-mediated platelet destruction. This drug has demonstrated to be…”
Get full text
Journal Article -
9
-
10
PB2102: IMPACT OF AUTOLOGOUS STEM CELL TRASPLANTATION IN AL AMYLOIDOSIS. EXPERIENCE IN A SINGLE TERTIARY HOSPITAL
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
11
Comparison of Azacitidine and Decitabine for the Treatment of Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
Published in Blood (05-11-2020)“…Introduction: Decitabine and azacitidine have been increasingly used to treat patients with acute myeloid leukemia (AML) who are elderly or not suitable for…”
Get full text
Journal Article -
12
AML-013: Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia – A Retrospective Study of a Real-World Setting
Published in Clinical lymphoma, myeloma and leukemia (01-09-2020)“…In November 2018, the FDA approved the use of venetoclax combined with hypomethylating agents (HMA) or low-dose cytarabine (LDAC) in patients with newly…”
Get full text
Journal Article -
13
-
14
Use of Eltrombopag after Romiplostim in Primary ITP Patients
Published in Blood (06-12-2014)“…Background: The trombopoietin receptor agonists (TRAs) romiplostim and eltrombopag are effective and safe in the treatment of chronic immune thrombocytopenia…”
Get full text
Journal Article